Li‐Yuan Bai
ORCID: 0000-0001-7739-4077Also affiliated with China Medical University, China Medical University Hospital
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 3 papers. Top paper: “O-2 Phase III study of NUC-1031 + cisplatin vs gemcitabine + cisplatin for first-line treatment of patients with advanced biliary tract cancer (NuTide:121)”.
I. Bazin, Do‐Youn Oh, O. Zubkov, V. Breder, Li‐Yuan Bai +16 more
Kohei Shitara, Katrin Marie Sjoquist, Andrew Martin, Anthony Jaworski, Niall C. Tebbutt +16 more
Axel Grothey, Darren Sigal, Heinz-Josef Lenz, Howard S. Höchster, Yee Chao +5 more